Hengrui and Kailera Present Clinical Data for HRS9531 and HRS-7535 at ADA 2025

Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics announced the presentation of six abstracts at the American Diabetes Association's 85th Scien...
Home/KnloSights/Clinical Trial Updates/Hengrui and Kailera Present Clinical Data for HRS9531 and HRS-7535 at ADA 2025